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Abstract
Experiments with somatic cell nuclear transfer, inter-cellular hybrid formation_ENREF_3, and ectopic expression of
transcription factors have clearly demonstrated that cell fate can be dramatically altered by changing the epigenetic state of
cell nuclei. Here we demonstrate, using chemical fusion, direct reprogramming of the genome of human embryonic
fibroblasts (HEF) into the state of human fetal liver hFL CD34+ (hFL) hematopoietic progenitors capable of proliferating and
differentiating into multiple hematopoietic lineages. We show that hybrid cells retain their ploidy and can differentiate into
several hematopoietic lineages. Hybrid cells follow transcription program of differentiating hFL cells as shown by genome-
wide transcription profiling. Using whole-genome single nucleotide polymorphism (SNP) profiling of both donor genomes
we demonstrate reprogramming of HEF genome into the state of hFL hematopoietic progenitors. Our results prove that it is
possible to convert the fetal somatic cell genome into the state of fetal hematopoietic progenitors by fusion. This suggests a
possibility of direct reprogramming of human somatic cells into tissue specific progenitors/stem cells without going all the
way back to the embryonic state. Direct reprogramming of terminally differentiated cells into the tissue specific progenitors
will likely prove useful for the development of novel cell therapies.
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Introduction
Somatic cells have been reprogrammed into the embryonic state
[1,2,3,4,5,6], as well as into several types of terminally differentiated
cells, including myoblasts [7], macrophages [8], beta-cells [9], and
neurons [10]. However, the conversion of the somatic cell genome
into a state of tissue-specific stem cells/progenitors has not been
demonstrated before now. Embryonic stem (ES) cellscan differentiate
into many cell types but can remain phenotypically and transcrip-
tionally stable in vitro in the appropriate culture conditions. Most
terminally differentiated cells are also phenotypically and transcrip-
tionally stable both in vitro and in vivo. On the contrary, hematopoietic
progenitors are uni-, bi-, or multi-potent since they can differentiate
into mature blood cells types [11], but have a limited self-renewal
capacity and are therefore transcriptionally unstable in vivo. While it is
possible to prospectively isolate progenitors [12]_ENREF_11 and to
demonstrate their differentiation potential they cannot be reliably
maintained in undifferentiated state in culture. Here we demonstrate
the reprogramming through cell fusion of the genome of human
embryonic fibroblasts (HEF) into a transcriptionally unstable state of
human fetal liver CD34
+ (hFL) hematopoietic progenitors capable of
proliferating and differentiating into multiple hematopoietic lineages.
Results
We successfully produced hybrids by fusing HEFs and hFL cells
following synchronization of both cell types in metaphase II and
knock-down of p53. Knock-down of p53 was tested because of the
reported increased efficiency of the reprogramming of somatic
cells into induced pluripotency state (iPS) in its absence [13,14,15].
Cells were synchronized in mitosis because we hypothesized that
the dispersion of transcription factors through the cytoplasm in
metaphase as a result of the nuclear membrane break down might
contribute to a temporary relaxation of the transcriptional control
that defines cell identity and may favor reprogramming [16]. In
addition, the synchronization in mitosis excludes the possibility of
an incompatibility between the cell cycles of the fusion partners.
This is important since such a fusion, for instance, between a cell
in mitosis with a cell in interphase would lead to cell death.
HEFs were transduced with retroviral vectors expressing anti-
p53 shRNAs and a puromycin resistance marker and selected for
puromycin resistance. hFL cells were transduced with a lentivirus
expressing GFP and anti-p53 shRNA and selected using
fluorescence activated cell sorting (FACS) (Fig. 1A, B, C; see
Materials and Methods). These two selection markers were then
used to select hybrid cells using the scheme described in Fig. 1A
and 1B. Briefly, the genetically modified HEF and hFL cells were
synchronized in mitosis with the help of nocodazole and
chemically fused using polyethylene glycol (PEG). Non-fused
HEFs were eliminated, as they were able to attach to the tissue
culture plates and did not express GFP. Non-fused hFL cells were
selected against chemically using puromycin. Two days after
fusion GFP expressing cells (Fig. 1D) were FACS-sorted for GFP
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18265Figure 1. Generation of hybrid cells by fusion of hFL cells and HEFs. A. HEFs and hFL cells from two donors were infected with retroviral or
lentiviral vectors expressing anti-p53 shRNAs, a drug resistant marker or GFP. Infected cells were synchronized in metaphase, chemically fused, and
differentiated towards the erythroid lineage in liquid culture after limiting dilution, and in the presence of antibiotics. B. Schematic of the experiment.
C. FACS analysis demonstrating GFP expression by hFL cells before fusion. D. FACS analysis demonstrating GFP expression by hybrid cells 7 days after
fusion. E. PCR amplification showing that the retroviral vectors used to infect HEFs for p53 knock-down and drug-resistance selection can be
detected in the hybrids. F. Examples of colonies detected at day 14, the end of the period of expansion, chemical selection, and erythroid
differentiation of the hybrid cells. Magnification is 610 for two upper rows and 620 for the bottom row. Bottom row shows random computer
chosen images of cells from different colonies. G. Representative example of the number of hybrid colonies in an experiment.
doi:10.1371/journal.pone.0018265.g001
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differentiation toward the erythroid lineage (Fig. 1A, B; see
Materials and Methods).
One week after fusion, we observed the emergence of GFP
positive, puromycin resistant colonies (Fig. 1F), which ranged in
size from 23 cells (Fig. 1F, middle row, the smallest colony
observed) to more than 200 cells (Fig. 1F, upper row, the largest
colony observed). We detected 363 colonies in 208 wells out of
total 1056 wells (Fig. 1G). Assuming that each colony was a
progeny of a single hybrid cell, efficiency of successful fusion/
amplification was 0.018% (363 cells out of 2*10
6 hFL cells used for
fusion). Observed cells expressed CD235a (Glycophorin A)
(Fig. 1F) suggesting that they had differentiated along the erythroid
lineage. As expected they were also GFP positive and puromycin
resistant.
To confirm that the puromycin-resistant GFP expressing cells
were generated through fusion, we first assayed the genetic
markers carried by the donor cells used for the fusion. Using
polymerase chain reaction (PCR), we observed that drug-resistant
GFP positive cells contained the retroviral insert introduced into
the HEFs (Fig. 1E). We then determined the DNA content of the
hybrids. We mixed puromycin-resistant GFP-positive cells that
went through selection and differentiation in liquid culture
(Fig. 1A) with freshly isolated hFL that served as a reference
diploid internal control. We then stained the mixture with DAPI
and anti-CD235a antibody, and analyzed it using a Laser
Scanning Cytometer (LSC) (Fig. 2). The GFP-positive drug-
resistant cells contained twice the relative amount of DNA
compared to reference cells (Fig. 2B, C), and were tetra-ploid or
octa-ploid (Fig. 2C). Single-cell analysis demonstrated that most
GFP-positive cells had a higher DNA content compared to the
reference cells and were also CD235a positive (Fig. 2D). Together,
these experiments confirmed that the fusion was successful.
If the HEF genome was reprogrammed to the state of a CD34
+
hFL cell, then the hybrid cells should have retained the multi-
lineage potential of hFL cells. To test this assumption we
conducted colony forming unit (CFU) assays in methyl-cellulose
(Fig. 3); only hFL cells but not HEFs can spontaneously
differentiate into different hematopoietic lineages in the assay.
Fusion was conducted as described above except that the GFP and
puromycin resistance markers were swapped. (Fig. 3A,B; see
Materials and Methods). After two days of chemical selection, GFP
positive cells were isolated using FACS and seeded in methyl
cellulose containing puromycin for CFU assays. The cells gave rise
to colonies with morphologies resembling CFU-M, CFU-G, CFU-
GM and poorly hemoglobinized BFU-E (Fig. 3C). All colonies
were GFP positive suggesting that they contained the genome of
the HEFs (Fig. 3D). Identification of the colonies was confirmed by
a Wright-Giemsa stain (Fig. 3E). It revealed that that the colonies
contained cells with erythroid, macrophage, granulocyte, and
megakaryocyte precursors morphologies (Fig. 3E). FACS analysis
of these GFP positive colonies revealed a large population of cells
expressing CD235a and a much smaller population of monocytes,
megakaryocytes, and neutrophils expressing CD14, CD61, and
CD16 respectively. As expected, we failed to detect cells expressing
CD19, a marker commonly expressed by cells differentiating
toward the lymphoid lineage (Fig. 3F).
We hypothesized that the reprogrammed HEFs should have
acquired the transcriptional profile of the hFL fusion partner. To
determine whether the hybrid cells resemble the hFL cells, or on
the contrary retained the transcription states of both types of fused
cells, we performed a genome-wide transcriptional profiling (Fig. 4)
Figure 2. Hybrid cells retain ploidy and differentiate along the erythroid lineage. A. GFP expression and DNA content analysis of a mixture
of hybrid cells on day 14 of erythroid differentiation and freshly isolated hFL (reference) cells. B. DNA content analysis of reference GFP- cells. C. DNA
content analysis of hybrid GFP+ cells. D. Morphology, DNA content, GFP, and CD235 expression analysis of reference diploid and tetraploid cells and
hybrid tetraploid and octaploid cells.
doi:10.1371/journal.pone.0018265.g002
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differentiated along the erythroid lineage (dhFL), and hybrid cells
differentiated in the same conditions (dHybrids). Pearson product
moment correlations (PMCC) showed that the transcriptional
profiles of the hybrid and dhFL cells were closest to each other
(PMCC=0.994) and that the profile of the dHybrids was
significantly different from that of the HEF cells (PMCC=0.797),
(Fig. 4B). PMCC between the dHybrid and the dhFL cells
Figure 3. Hybrid cells differentiate into several hematopoietic lineages. A. HEFs and hFL cells were respectively infected with lentivirus
expressing anti-p53 shRNA and GFP, and retrovirus expressing anti-p53 shRNA and puromycin selection marker. They were synchronized in
metaphase, chemically fused, and seeded in methylcellulose medium for colony forming unit assays. B. Diagram of the experiment. C. Typical
colonies that arose in the CFU assay (magnification 64). D. Fluorescent images of the colonies in C. E. Wright-Giemsa stain of a cytospin of cells
obtained from the CFU assay colonies (magnification 6100). F. FACS analysis of cells from the colonies formed in the CFU assay.
doi:10.1371/journal.pone.0018265.g003
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similar (Fig. 4B).
The above experiments demonstrated that the hybrid cells had
adopted a dhFL transcriptional profile but did not formally prove
that the HEF genome was fully reprogrammed since the HEF
genome could have been retained as a silent cargo [17,18,19]. The
extent of reprogramming of the adopted genome in fusion
experiments has been a long standing question that can now be
answered using massively parallel transcriptome sequencing
combined with genome-wide single nucleotide polymorphism
(SNP) analysis. To evaluate the extent of the reprogramming of the
genome of HEFs in the hybrid cells, we conducted a genome-wide
SNP analysis in both donors. We reasoned that (i) if the HEF
genome was fully reprogrammed, erythroid-specific genes would
be expressed at similar levels whether they were derived from the
HEF or hFL genomes and (ii) that fibroblast specific genes would
be down-regulated in the hybrids. To test this hypothesis, we first
identified SNPs in the genomic DNA of the two donors using an
Affymetrix SNP Array (Fig. 4D; see Materials and Methods). We
then used a colony of hybrid cells differentiated towards the
erythroid lineage (,100 cells) (Fig. 1F, G) to construct a cDNA
library (see Materials and Methods) that was subsequently deep-
sequenced on an Illumina GAII genome analyzer. Twenty-seven
millions sequence reads were then aligned to the transcriptome
and SNPs were called using the SOAP and SOAPsnp packages
(see Materials and Methods). To unambiguously identify which
genome was the source of a particular transcript, we focused on
SNPs that were different in the two donors and either homozygous
in both donors or heterozygous in only one donor. We identified
71 statistically robust (mRNA-SEQ read count .5) SNPs in 64
polymorphic genes (Fig. 4E). These genes were found in
chromosomes 1, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 22
(Table S1). Quantitative analysis revealed that when the SNPs
were homozygous, the ratio of transcripts was 59.667.3%/
40.467.3% (theoretical ideal value 50%/50%). For heterozygous
SNPs, the ratio was 73.3610.3%/26.4610.3% (theoretical ideal
value 75%/25%). To extend this analysis, we then focused on
transcripts that were at least 4 times over-expressed in either hFL
or HEF cells. We found 11 SNPs in 7 genes over-expressed in hFL
and 1 SNP in 1 gene (ACTG1 – actin gamma 1; implicated in
hearing loss and cell viability decrease when mutated) over-
expressed in HEF that satisfied these criteria (Fig. 4E, F; Table 1).
Four out of these 7 genes were known to be hematopoietic
(RHCE, SPTA1, LMO2, FECH). Mutations in two of these four
genes were implicated in hematopoietic diseases; SPTA1 –
spherocytosis, FECH – erythropoietic porphyria. Quantitative
analysis revealed that when the SNPs were homozygous, the ratio
of HEF-derived/hFL-derived transcripts was 4163.29%/
5963.29%; theoretical ideal value 50%/50%). For one donor’s
heterozygous SNPs the ratio of HEF-derived/hFL-derived tran-
scripts was 2266.3%/7866.3% (theoretical ideal value 25%/
75%; all values are presented as (X 6 (Standard Deviation)).
These analyses clearly demonstrate that the HEF genome was
reprogrammed rather than carried as a silent cargo [18,19].
Discussion
In summary, this work shows that HEF/hFL hybrids proliferate
and retain their ploidies for at least 14 days in vitro, and are capable
of differentiating into several myeloid lineages. The differentiated
progeny of the hybrids followed a transcriptional program
undistinguishable from the differentiated progeny of the hFL cells
suggesting that the hFL genome was unaffected by the HEF
genome, and that the HEF genome was completely repro-
grammed. It has to be noted that it is yet to be determined if
adult human fibroblasts can be reprogrammed into the state of
adult multi-potent hematopoietic progenitors.
Our results therefore prove that it is possible to completely
convert an embryonic somatic cell genome into a state of fetal liver
hematopoietic progenitors without having to first revert to an
embryonic state. This suggests that these cells contain factors
capable of overriding the factors defining the cellular identity of
the HEFs and that it might be possible to identify a set of
transcription factors that could be used to directly reprogram
somatic cells into tissue specific stem cells/progenitors.
During preparation of this work for publication we learned
about the direct conversion of human fibroblasts to multi-lineage
blood progenitors by ectopic expression of OCT4 (POU5F1) [20].
This fascinating discovery reconfirms our own conclusions
presented here and opens up new opportunities in the area of
cellular reprogramming. It remains to be seen whether OCT4
dependent conversion of fibroblasts is tissue type independent and
will be useful for generation of adult type erythrocytes as well as
common lymphoid progenitors. Direct reprogramming of termi-
nally differentiated cells into tissue-specific progenitors will likely
prove useful for the development of novel cell therapies, as well as
a better understanding of mechanisms of reprogramming [21,22],
cellular plasticity in vitro [22] and in vivo [23], as well as of human
development.
Materials and Methods
Cell Culture
HEFs and hFL CD34+ cells were isolated from discarded tissue
of aborted fetuses. All experiments were approved by the
Committee on Clinical Investigations (CCI) and conducted
according to the CCI approved protocols and written informed
consent (English and Spanish) (CCI# 2006-390 ‘‘In vitro red blood
cell production’’, and CCI# 2008-201’’Feasibility pilot studies of
therapies for sickle cell disease, thalassemia and other acquired
and inherited blood, vascular and metabolic disorders’’). Briefly,
fetal liver tissue was mechanically homogenized, trypsinized
(0.05% Trypsin solution in PBS) for 20 minutes at 37uC.
Mononuclear cells were isolated using gradient centrifugation in
HISTOPAQUE-1077 (Sigma-Aldrich, St. Louis, USA). hFL
Figure 4. Transcriptional reprogramming of HEF genome in hybrid cells. A. Total RNA from about 1500 hybrid cells (12 colonies) and equal
numbers of hFL and HEF cells (donors 19 and 24) were analyzed using Affymetrix 1.0 ST Array. B. Comparison of genome-wide transcriptional profiles
of dHybrids, dhFL cells, and HEFs (donors 19 and 24). C. Comparison of genome-wide transcriptional profiles of dhFL and HEF for two donors (donors
19, 24). PMCCs for pair-wise combinations of expression profiles of hybrid cells, hFL cells, and HEFs are shown inside each graph in B and C. The red
dots show 18 genes that are highly over-expressed in dhFL and that contain SNPs found using SNP Array and satisfying criteria shown in E (see also
Materials and Methods). D. An outline of the paradigm that was used to unambiguously identify origin of transcripts in hybrid cells. E. Number of
reads mapping hybrids SNPs originating from dhFL24 or HEF19 genomes. The red dots show the SNPs from Table 1 having a total number of
mapping reads greater than 5. F. Change of transcription levels of representative genes expressed by the reprogrammed HEF genome inside hybrid
cells. Green dots and arrows show up-regulation of expression of dhFL-specific genes with verified SNPs (see Table 1). A red dot and arrow show
down-regulation of HEF specific gene with verified SNP (see Table 1). The scale in all graphs is in log2(X). G. An example of RNA-Seq analysis for a
gene SPTA1 with a partial alignment of Illumina reads with SNPs coming from transcripts of two different genomes (see Table 1, row 6).
doi:10.1371/journal.pone.0018265.g004
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(StemCell Technologies, Vancouver, Canada) according to the
manufacturer’s instructions. HEFs were isolated by trypsinization
and mechanical dispersion of fetal tissue. Cell suspension was
plated in the cell culture medium made of DMEM, 10% FBS,
Pen/Strep. Cells were selected by their ability to adhere to the
bottom of the culture dish and proliferate. All experiments were
conducted with HEFs younger than passage four.
FL CD34+ cells and hybrid fused cells were expanded, and
differentiated in liquid culture as previously described [24]. Briefly,
FL CD34+ cells and hybrids were seeded in serum-free basal
medium StemSpan (StemCell Technologies, Vancouver, Canada)
supplemented with Hydrocortisone (10
26 M), SCF 50 ng/ml,
Flt3L (16.7 ng/ml), BMP4 (6.7 ng/ml), IL3 (6.7 ng/ml), IL11
(6.7 ng/ml), EPO (1.3 U/ml). After 7 days the concentrations of
the cytokines were changed as follows: Hydrocortisone (10
26 M),
SCF (20 ng/ml), IGF1 (20 ng/ml), IL3 (6.7 ng/ml), IL11 (6.7 ng/
ml), EPO (2 U/ml). The medium used for culturing hybrid cells
and cells infected with retroviral vectors conferring puromycin
resistance was supplemented with puromycin (10 mg/ml).
Viral vectors
Three different species of short hairpin RNA (shRNA) were
used to knock-down expression of p53 in HEFs and FL CD34+
cells, anti-p53 shRNA1, shRNA2, and shRNA3. Anti-p53
shRNA1 was delivered and expressed using lentiviral vector
pLVUH-shp53-GFP [25] (Addgene 11653). Anti-p53 shRNA2
and anti-p53 shRNA3 were delivered and expressed using
retroviral vectors pMKO.1 puro [26,27] (Addgene 10671,
10672). Lentiviral and retroviral vectors were packaged as
described [25,28]. Both types of viruses were purified and
concentrated using Fast-Trap Lentivirus Purification and Con-
centration Kit (Millipore, Billerica, USA). Primers used for
pMKO.1 puro shRNA2 and shRNA3 detection were as following:
pMKO.1_shRNA2_F: 59-ACT CCT TCT CTA GGC GCC
GGA ATT-39; pMKO.1_shRNA2_B: 59-CCA CTG TGC TGG
CGA ATT CA-39; pMKO.1_shRNA3_F: 59-CTT CTC TGG
CGC CGG AAT TGA A-39; pMKO.1_shRNA3_B: 59-ACC
ACT GTG CTG GCG AAT TCA C-39. Primers were specific for
the construct and designed to amplify a fragment of the viral
construct of about 350 bp.
Fusion
Chemical cell fusion was performed using polyethylene glycol
(PEG 1500, Roche Applied Science, Indianapolis, USA) according
to manufacturer’s instructions and as previously described [3,21].
Briefly, before fusion cells were cultured for 10–12 hours in the
presence of 0.1–0.2 mg/ml of nocodazole to arrest and synchro-
nize them in mitosis [29]. For fusion 2*10
6–1*10
7 HEFs and FL
CD34+ cells were mixed in 15 ml in StemSpan medium, spun
down, and drained of supernatant. Broken by gentle agitation cell
pellet was slowly mixed with PEG 1500 (50%, 1 ml at 37uC). Total
volume of the cell suspension was gradually brought to 10 ml.
Cells were spun down, washed twice, and seeded in a puromycin
supplemented medium for further experimentation.
Transcriptional profiling
A genome-wide transcriptional profiling of donor and hybrid
cells was performed using human gene Affymetrix 1.0 ST Array
according to the manufacturer’s protocol. We used the total RNA
from about 1500 hybrid cells (12 colonies) and equal numbers of
hFL and HEF cells (donors 19 and 24) as starting material for the
expression analysis. All signals were normalized using the Robust
Multichip Average (RMA) algorithm through RMA Express
software. RMA normalization consists of three steps: a background
adjustment, a quintile normalization [30], and summarization.
Expression profiles for each cell type were correlated against one
another using Pearson product-moment correlation coefficients
(PMCC). PMCCs were calculated as follows:
r~
1
n{1
X n
i~1
Xi{  X X
Sx
  
Yi{  Y Y
Sy
  
,
where is standard score,   X X is sample mean, Sx and Sy are
standard deviations for data sets X and Y respectively.
Table 1. List of SNPs demonstrating effective reprogramming of HEF genome in dHybrid cells.
Chromo
some Position Gene
Ref.
Gen.
Consensus
Genome
1
st Best
Base
1
st Best
Freq.
2
nd Best
Base
2
nd Best
Freq.
HEF19
Genome
hFL24
Genome
Expression
dhFL24-HEF19
1 25589895 RHCE G G/C C 53\82 G 28\82 CG GG 4.62
1 25589952 RHCE C G/C C 40\45 G 5\45 CC CG 4.62
1 117968400 FAM46C C T/C T 88\112 C 24\112 CT TT 5.32
1 117968722 FAM46C A G/A G 87\113 A 26\113 GA GG 5.32
1 156847383 SPTA1 G G/A A 45\72 G 27\72 GA AA 7.1
1 156947511 SPTA1 T T/C T 33\45 C 12\45 TT CT 7.1
11 33837472 LMO2 T A/T T 7\10 A 3\10 TT AT 2.37
11 33837592 LMO2 T T/C C 5\8 T 3\8 CC TC 2.37
14 36219544 SLC25A21 G G/A G 4\7 A 3\7 GA GG 5.24
17 7501560 ATP1B2 T G/T T 14\19 G 3\19 N/A TT 2.84
17 77092614 ACTG1 G G/A G 4\7 A 3\7 GA AA 23.82
18 53391503 FECH C T/C C 16\21 T 5\21 TC CC 3.79
SNPS from list A and list B (see Materials and Methods), showing genomic position, the hybrid consensus sequence vs. reference sequence identified using SOAPsnp,
frequencies for the 1
st and 2
nd best base, genome reads for HEFs and hFL cells determined using Affymetrix SNP6.0 array, and differential expression levels for dhFL cells
and HEFs according to the RNA-seq analysis. The 1
st/2
nd best base frequency is the count of uniquely aligned reads corroborating the 1
st/2
nd best base divided by the
overall sequencing depth of the site. Green and red rows represent genes that are respectively up- and down-regulated in HEF genome inside hybrid cells.
doi:10.1371/journal.pone.0018265.t001
Fibroblasts into Hematopoietic Progenitors
PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e18265Single Nucleotide Polymorphism (SNP) analysis
Genome-wide SNP analysis of donor cells was conducted using
Affymetrix SNP Array 6.0. Genomic DNA was extracted from
hFL and HEF cells and hybridized on an Affymetrix SNP6.0 array
in order to determine SNPs localization and assess the effective
reprogramming of the HEF genome in the hybrid cells.
From the total number of identified SNPs, only the ones located
within exons were selected, using the Galaxy website (http://main.
g2.bx.psu.edu). We used the refseq exons annotation file and
looked for the overlap between all exons genomic intervals and
SNPs positions. Once the list of exonic SNPs was generated, it was
imported into Microsoft Access. Therein, we selected for SNPs
that were different in the two donors, and either homozygous in
both donors or heterozygous in only one donor. Finally we added
a last filtering step allowing us to keep only the SNPs located in
genes that were over-expressed at least 4 times in hFL cells when
compared to HEFs. We generated a list (List A) of 74 SNPs in 30
Genes.
Transcriptome-wide SNP analysis
We constructed a cDNA library from total RNA from a single
colony of hybrid cells (0.1–1 ng) as described elsewhere
[31,32]_ENREF_27_ENREF_19 with some modifications. We
modified primers used for reverse transcription and second strand
cDNA synthesis to include a rare-cutter restriction site (BstU1)
between unique sequences (UP1 and UP2) and poly (T) fragments
of the primers. This allowed us to eliminate UP1 and UP2 anchor
sequences from the cDNA library which reduced a number of
non-specific reads in RNA-seq. UP1_BstU1 primer: ATA TGG
ATC CGG CGC GCC GTC GAC CGC GTT TTT TTT TTT
TTT TTT TTT TTT T; UP2_BstU2 primer: ATA TCT CGA
GGG CGC GCC GGA TCC CGC GTT TTT TTT TTT TTT
TTT TTT TTT T. We increased time of the reverse transcription
to 1 hour. Second-strand synthesis was conducted in a two-cycle
PCR reaction (95uC for 2 min, 50uC for 3 min, 72uC for 6 min).
cDNA amplification was conducted with UP1_BstU1 and
UP1_BstU2 primers using 25-cycle PCR reaction (95uC for
30 sec, 68uC for 1 min, 72uC for 6 min plus 6 sec for each
consecutive cycle). Amplified cDNA was restricted with the BstU1
endonuclease and purified with Qiaquick PCR purification kit to
remove UP1 and UP2 anchor sequences (Figure S1 Materials).
The cDNA library was submitted for Massive Parallel
Sequencing using the Illumina GA2x platform. The 27*10
6
sequences obtained were aligned against the Human genome
using SOAP (Short Oligonucleotide Analysis Package) aligner.
Finally SOAPsnp, a re-sequencing consensus sequence builder,
allowed us to obtain the complete list of 3.7*10
4 SNPs present in
the hybrid exons (List B). Since both donors were females we
found SNPs in transcripts of all chromosomes but the Y
chromosome (Table S2).
Lists A and B were crossed in order to determine SNPs present
in hFL, HEF and hybrid cells. We identified 71 statistically robust
(read count .5) SNPs in 64 polymorphous genes regardless of the
expression pattern in HEF and hFL. We chose the SNPs that were
found in exons of genes that were differentially expressed in hFL
when compared to HEF (.4 times difference). We identified 11
SNPs in 7 genes up-regulated in the hybrid cells (hFL specific), and
1 SNPs in 1 genes down-regulated in the hybrid (HEF specific; see
Table 1).
Supporting Information
Figure S1 Construction of a cDNA library. A. cDNA
library constructed from a single colony of hybrid cells. 1.5%
agarose gel electrophoresis of the cDNA amplified from a single
colony of hybrid cells (0.1–1 ng of RNA). 1/10 of total cDNA
library were loaded (lane 1). 10 ml out of 100 ml of total cDNA
restricted with BstU1 (lane2). B. PCR amplification of fragments
of genes over-expressed in dhFL cells from the cDNA library.
Lanes 1–8 are show PCR products for NM_004360 (CDH1),
NM_005640 (TAF4b), NM_020485 (RHCE), NM_003126
(SPTA1), NM_000347 (SPTB), NM_004091 (E2F2),
NM_021624 (HRH4), NM_144682 (SLFN13). Primers for PCR
amplification were designed to bind to two different exons of a
gene.
(PDF)
Table S1 List of SNPs and weighted read counts. SNPs
found in the hybrid mRNA sequences, showing genomic position,
the hybrid consensus sequence vs. reference sequence identified
using SOAPsnp, frequencies for the 1
st and 2
nd best base, actual
genome reads for HEFs and hFL cells determined using
Affymetrix SNP6.0 array, and the weighted counts of reads
originating from hFL24 or HEF19. When both dhFL24 and
HEF19 are homozygous for a gene, the weighting coefficient is 1.
If one of the donor is heterozygous for a gene (AB) and the other
one is homozygous (AA or BB), a coefficient of 0.66 was attributed
to the over-represented allele, and 0.33 to the under-represented
allele. The results are shown in the last 2 columns of the table.
(PDF)
Table S2 Repartition of interrogated genes by chromo-
some. The first column contains the number of genes covered by
the Affymetrix HuGene.0.1_st micro array for each chromosome,
the second columns contains the genes covered in the Affymetrix
SNP-6.0 chip, and the last fields shows the number of genes found
in the SOAP SNPs analysis run on the hybrid mRNA-seq data.
(PDF)
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